Skip to main content
. 2019 Jan 4;8(1):44. doi: 10.3390/jcm8010044

Table 1.

Effects of pirfenidone (PFD) treatment on cell cycle progression in LNCaP cells.

PFD (mg/mL) Phase (%)
G0/G1 S G2/M
0 61.8 ± 0.9 19.2 ± 0.3 17.8 ± 0.5
0.1 64.9 ± 0.7 ** 16.8 ± 0.7 * 17.2 ± 0.5
0.3 72.3 ± 0.7 *** 12.0 ± 0.2 *** 14.7 ± 0.5 **

*, p < 0.05; **, p < 0.01; ***, p < 0.001 versus vehicle-treated control.